Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease breast cancer
Symptom C0085635|flashes
Sentences 16
PubMedID- 26067931 Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis.
PubMedID- 20508951 Hot flashes in women with breast cancer are associated with poorer subjective sleep quality and thought to contribute to poorer, less consolidated sleep by increasing awakenings and sleep stage changes 3.
PubMedID- 20182796 Hot flashes in breast cancer survivors (bcs) receiving adjuvant aromatase inhibitor (ai) therapy are common, but risk factors for these symptoms are ill-defined.
PubMedID- 23383974 Acupuncture for the treatment of hot flashes in patients with breast cancer receiving antiestrogen therapy: a pilot study in korean women.
PubMedID- 21188095 Antidepressants such as paroxetine and venlafaxine have been shown to be effective in reducing hot flashes in women with breast cancer, and several small studies have suggested that these agents may also be beneficial in men with prostate cancer.50,51 as depression and emotional lability can also be a consequence of hormonal therapy,45 antidepressants may also have other positive effects on the patient.
PubMedID- 24477325 Conclusions: data from six prospective analyzed studies indicate at least 3-month effects after the end of acupuncture treatment for flashes in women with breast cancer and men with prostate cancer.
PubMedID- 21989181 In this study breast cancer survivors with hot flashes were randomized to either a therapist delivered hypnosis intervention or a wait-list control condition.
PubMedID- 23984103 However, it proved efficacious in controlling hot flashes in women with breast cancer, and for that reason it was also tested in men under adt.
PubMedID- 24250540 Found no alleviating effect of soy phytoestrogens on postmenopausal hot flashes in women with breast cancer (14, 15).
PubMedID- 20179808 Management of hot flashes in women with breast cancer.
PubMedID- 25031967 One study from 2008 conducted among 60 female breast cancer survivors with hot flashes evaluated the effect of 5 weekly hypnosis sessions vs. no treatment (elkins et al., 2008).
PubMedID- 21911720 Conclusion: venlafaxine and clonidine are effective treatments in the management of hot flashes in patients with breast cancer.
PubMedID- 23435567 Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: cepo review and recommendations.
PubMedID- 23017618 Bupropion for control of hot flashes in breast cancer survivors: a prospective, double-blind, randomized, crossover, pilot phase ii trial.
PubMedID- 21151674 Hot flashes in breast cancer survivors and an association with calcium supplement use.
PubMedID- 26130979 Methods: a pubmed search for recent articles on the effects of sgb for the treatment of hot flashes in patients with breast cancer identified 11 articles published between 2005-2014.

Page: 1